CARE Stock Analysis: Buy, Sell, or Hold?
CARE - Carter Bankshares, Inc. Common Stock
$31.93
-0.64 (-1.95%)
▼
5d:
-3.84%
30d:
+9.63%
90d:
+30.84%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Jul 23, 2026
9d
Get Alerted When CARE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CARE shows positive signals but monitor for confirmation. Market pricing in 9.9% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: CARE shows positive signals but monitor for confirmation. Market pricing in 9.9% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.00
Based on -24.5% avg growth
INTRINSIC VALUE TODAY
$3.10
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CARE is currently trading at $31.93, which is considered fair relative to its 30-day fair value range of $29.55 to $33.22. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.7) compared to its historical average (9.6). At these levels, the market is pricing in 9.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CARE is in a strong uptrend. The price is currently testing key support at $31.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $28.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CARE is in a strong uptrend. The price is currently testing key support at $31.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $28.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$29.55 -
$33.22
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 14.0% above Wall St target ($28.00)
- NEUTRAL: PE elevated vs history but 9.9% growth expectation is conservative given 901% recent growth
Trading Range Analysis
30-Day Trading Range
$29.55 -
$33.22
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.10
(3.4%)
Support & Resistance Levels
Support Level
$31.29
Resistance Level
$35.03
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.69
Wall Street Target
$28.00
(-14.0%)
Revenue Growth (YoY)
260.0%
Earnings Growth (YoY)
900.8%
Profit Margin
41.8%
Valuation Premium vs History
+9.9% premium
PE vs Historical
12.7 vs 9.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.9%
(market-implied from PE analysis)
1-Year Target
$35.78
(+10%)
2-Year Target
$39.33
(+21%)
3-Year Target
$43.22
(+33%)
3-Yr Target (if PE normalizes)
(PE: 13→10)
PE COMPRESSION
$32.71
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -53.0%)
$40.75
(+25%)
Base:
(SPY PE: 12.7, Growth: -53.0%)
$23.74
(-27%)
Bear:
(PE: 9.6, Growth: -53.0%)
$17.96
(-45%)
📈
Valuation based on Current Earnings
Trailing PE: 6.49 | Current EPS (TTM): $4.99
Bull Case
$18.31
(-44%)
Analyst growth -48.6%, PE expands to 7.1
Base Case
$16.65
(-49%)
Market implied -48.6%, PE stable at 6.5
Bear Case
$22.00
(-32%)
Severe decline -20.0%, PE contracts to 5.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM
Data refreshes hourly during market hours. Next update: 11:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CARE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Banks - Regional Stocks
Top-rated stocks in Banks - Regional by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HBAN
Huntington Bancshares In… |
STRONG BUY
21 analysts |
$20 | 66 BUY |
|
NU
Nu Holdings Ltd |
BUY
20 analysts |
$18 | 62 BUY |
|
WAL
Western Alliance Bancorp… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
|
FNB
F.N.B. Corp |
STRONG BUY
9 analysts |
$21 | 63 BUY |
|
BAP
Credicorp Ltd |
STRONG BUY
13 analysts |
$392 | 61 BUY |
Advanced CARE Option Strategies
Professional options setups generated by AI based on today's CARE price and gamma walls.
